Answers are grounded in this paper and cite their sources.
Purpose Spinal ependymomas (SE) are the most frequent primary spinal tumor, harboring NF2 mutations in most cases and characterized by development of solid and/or cystic masses and peritumoral edema associated with morbidity. To explore the developmental and cellular mechanisms underlying these lesions and establish a reliable preclinical model, we generated a mouse model with Nf2 inactivation in Foxj 1-expressing ependymal cells, after confirming FOXJ1 expression in SE cells. Methods FoxJ1Cre ERT ; Nf2 flox/flox mice were generated, Nf2 inactivation was induced at different developmental stages of high FoxJ1 expression (E16, P0–4, P15) using a tamoxifen-inducible system. Mice were monitored for up to 15 months, with extensive histopathological analysis and post-mortem MRI in selected cases. Multiplex immunofluorescence was performed to characterize proliferative ependymal regions and identify potential progenitor-like populations. Results Conditional Nf2 inactivation resulted in frequent ependymal proliferations (87%) and cystic dilations of the central canal (54%), mimicking human pathological features. These spinal proliferations were often associated with intracranial hydrocephalus and periventricular lesions, particularly after P15 induction. Early induction (E16, P0–P4) caused higher mortality and malformations, whereas the P15 cohort showed a reproducible phenotype with minimal lethality. No frank tumor formation was detected in any cohort. Human SE and mouse proliferative lesions shared FoxJ1⁺ ependymal cells and FoxO3⁺/GFAP⁺/S100β⁻ populations resembling immature radial glial-like progenitors. Conclusion Nf2 loss in differentiated ependymal cells induces frequently proliferation and cystic dilation of the central canal, characterizing early tumorigenic changes of SE. This mouse model provides a valuable preclinical platform for studying the earliest stages of SE pathogenesis and testing new therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Marijon et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: